• Join
  • Login
  • Contact

Search abstracts

Physiologically-based pharmacokinetic (PBPK) Modeling and Simulation in Pediatric Drug Development

  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: EDGINTON, Andrea (University of Waterloo, School of Pharmacy, Waterloo, Canada)
  • Co-author(s): Andrea Edginton: School of Pharmacy, University of Waterloo, Waterloo, Canada
  • Abstract:

    PBPK modeling is primarily used to support drug-drug interaction work with the area of pediatrics being second with regards to FDA submissions (1). Pediatric PBPK models are primarily used to estimate pediatric doses for safety + PK trials that may or may not include efficacy. Advanced modeling techniques for planning pediatric trials are expected


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses